Correspondence to letter to the editor on “Distinct tumor immune microenvironment modulation by anti-PD-1/PD-L1, VEGF, and CTLA-4 blockade provides a rationale for triplet therapy in hepatocellular carcinoma”
Abstract
Correspondence to letter to the editor on "Distinct tumor immune microenvironment modulation by anti-PD-1/PD-L1, VEGF, and CTLA-4 blockade provides a rationale for triplet therapy in hepatocellular carcinoma"
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Hepatocellular Carcinoma Treatment and Prognosis
Hepatitis B Virus Studies
Publication details
- Journal / source
- Clinical and Molecular Hepatology
- Volume
- 32
- Issue
- 3
- Pages
- e424–e426
- Publication date
- 27 January 2026
- Language
- EN